Tredje AP fonden Sells 319 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Tredje AP fonden trimmed its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 1.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,356 shares of the company’s stock after selling 319 shares during the period. Tredje AP fonden’s holdings in Henry Schein were worth $1,305,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of HSIC. Vanguard Group Inc. grew its position in Henry Schein by 1.7% during the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock worth $1,165,425,000 after buying an additional 260,537 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Henry Schein by 3.1% during the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after acquiring an additional 162,477 shares during the last quarter. Swedbank AB purchased a new position in shares of Henry Schein during the first quarter worth about $215,998,000. Fiduciary Management Inc. WI increased its position in shares of Henry Schein by 17.1% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock worth $172,947,000 after purchasing an additional 333,855 shares during the last quarter. Finally, Nuance Investments LLC raised its stake in Henry Schein by 6.2% in the second quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock valued at $119,440,000 after purchasing an additional 108,143 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

Shares of HSIC stock opened at $71.15 on Friday. The company has a market capitalization of $9.11 billion, a P/E ratio of 24.04, a PEG ratio of 1.88 and a beta of 0.86. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The stock has a 50 day moving average price of $69.89 and a two-hundred day moving average price of $70.38.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same quarter in the prior year, the company posted $1.31 EPS. The firm’s revenue for the quarter was up .0% compared to the same quarter last year. Analysts expect that Henry Schein, Inc. will post 4.75 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have commented on HSIC shares. JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Friday. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Robert W. Baird cut their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, UBS Group decreased their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $77.10.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.14% of the stock is owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.